KLA Corporation is losing ground in China because US export rules bar it from shipping certain semiconductor equipment into some Chinese fabs, CFO Bren Higgins said while presenting the company's September-quarter guidance.1
Competitors not subject to the same restrictions can still ship equivalent tools into those same fabs, Higgins said. That gap is producing direct share loss in one of KLA's largest markets.1
KLA's own risk assessment rates the exposure "major" in severity and "high" in likelihood, with 0.7 confidence in the finding.2
The mechanism is narrow but costly: it is not a blanket China ban, but a selective license restriction covering specific tool categories destined for specific fabs. Where KLA is blocked, rivals without matching restrictions fill the gap.1
For investors, the distinction matters. A market-wide slowdown would hit every equipment supplier serving China equally. A licensing asymmetry instead reallocates existing demand toward KLA's competitors, converting a policy cost into a direct, quantifiable market-share transfer rather than a shared industry headwind.2
Higgins tied the disclosure to the September-quarter outlook, signaling that Washington's export-control regime is now a standing input to KLA's guidance process rather than a one-time adjustment.1
China has historically been a top revenue source for US semiconductor-equipment makers, and KLA's process-control and inspection tools are used across chip fabrication. Losing access to any subset of that installed base carries recurring revenue implications, since equipment sales are typically followed by service and upgrade contracts.2
The disclosure adds KLA to a group of US chip-equipment suppliers, including Applied Materials and Lam Research, that have flagged China export controls as a drag on results in recent quarters. Unlike broader demand risks, this one is structural: it persists as long as the licensing gap between KLA and its non-US-restricted competitors remains open.2
KLA did not detail the dollar magnitude of the share loss in the disclosed information, and no revised revenue figures tied specifically to the restriction were provided.1
